Scurvy, the debilitating condition remembered as a disease of pirates, is still found in Canada.
The disease, which is caused by a vitamin C deficiency, can result in bruising, weakness, anemia, gum disease, hemorrhage, tooth loss, and even death if undiagnosed and untreated.
McMaster University researchers surveyed the data of patients of Hamilton's two hospital systems over nine years and found 52 with low Vitamin C levels. This included 13 patients who could be diagnosed as having scurvy, and an additional 39 who tested positive for scurvy but did not have documented symptoms.
Among those with scurvy, some were related to alcohol use disorder or to bariatric surgery but the majority were related to other causes of malnutrition such as persistent vomiting, purposeful dietary restrictions, mental illness , social isolation and dependence on others for food.
"Scurvy is seen as a disease irrelevant to the modern world , but it still exists, and clinicians caring for at-risk patients should be aware of it and know how to diagnose it," said John Neary, associate professor of medicine at McMaster and the senior author of the study published this month in the Journal of General Internal Medicine .
First author Kayla Dadgar, who did the research as a medical student at McMaster, said: "Scurvy should be a 'never event' in a healthy society. That it still occurs in Canada in our time indicates that we are not supporting vulnerable people as we should."
The patients with scurvy who were given Vitamin C had a rapid recovery of their symptoms. Explore further More information: Kayla Dadgar et al, Clinical Profile of Scurvy in Hamilton Since 2009: a Cohort Study, Journal of General Internal Medicine (2020). DOI: 10.1007/s11606-020-05636-1 Journal information: Provided by McMaster University Citation : Scurvy is still a thing in Canada (2020, January 18) scurvy-canada.html
Also in Industry News
How to decide whether or not to start treatment for prostate cancer?
Analysis of the SARS-CoV-2 proteome via visual tools
$65m investment increases British Patient Capital’s exposure to life sciences and health technology